Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,533
archived clinical trials in
Chronic Obstructive Pulmonary Disease

Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated:  11/9/2017
Scott & White Memorial Hospital
mi
from
Temple, TX
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated: 11/9/2017
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated:  11/9/2017
University of Utah
mi
from
Salt Lake City, UT
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated: 11/9/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated:  11/9/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated: 11/9/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated:  11/9/2017
Univ of Washington
mi
from
Seattle, WA
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated: 11/9/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated:  11/9/2017
Franciscan Research Center
mi
from
Tacoma, WA
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated: 11/9/2017
Franciscan Research Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated:  11/9/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated: 11/9/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated:  11/9/2017
Mission Internal Medicine Group
mi
from
Mission Viejo, CA
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated: 11/9/2017
Mission Internal Medicine Group
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated:  11/9/2017
Health Partners Research Foundation/Regions Hospital
mi
from
Saint Paul, MN
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Status: Enrolling
Updated: 11/9/2017
Health Partners Research Foundation/Regions Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Respiration Rate Monitoring in COPD Patients
Assessment of the Temporal Changes in Nightly Respiration Rate in Combination With a Daily Symptom Reporting Application for Facilitating Early Treatment of Symptoms in COPD Patients
Status: Enrolling
Updated:  11/14/2017
HGE Health Care Solutions
mi
from
Philadelphia, PA
Respiration Rate Monitoring in COPD Patients
Assessment of the Temporal Changes in Nightly Respiration Rate in Combination With a Daily Symptom Reporting Application for Facilitating Early Treatment of Symptoms in COPD Patients
Status: Enrolling
Updated: 11/14/2017
HGE Health Care Solutions
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous and Inhalation Implantation of Autologous Adipose-Derived Stromal Vascular Fraction Cells in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  11/21/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous and Inhalation Implantation of Autologous Adipose-Derived Stromal Vascular Fraction Cells in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 11/21/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Andalusia, AL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Andalusia, AL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Anniston, AL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Anniston, AL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Jasper, AL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Jasper, AL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tempe, AZ
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tempe, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tucson, AZ
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tucson, AZ
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Fayetteville, AR
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Huntington Beach, CA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Rancho Mirage, CA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Colorado Springs, CO
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Altamonte Springs, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Deland, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Deland, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Kissimmee, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Miami, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Pensacola, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Pensacola, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Port Orange, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Conyers, GA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Conyers, GA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Duluth, GA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Duluth, GA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
New Orleans, LA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Slidell, LA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Slidell, LA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Sunset, LA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Sunset, LA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Columbia, MD
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Columbia, MD
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Edina, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Edina, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Fridley, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Fridley, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigator Site
mi
from
Minneapolis, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigator Site
mi
from
Minneapolis, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Plymouth, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Henderson, NV
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Henderson, NV
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis
mi
from
New York, NY
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Charlotte, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Cornelius, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Cornelius, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Gastonia, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Gastonia, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Hickory, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Hickory, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
High Point, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
High Point, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Huntersville, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Huntersville, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Winston-Salem, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Cincinnati, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Columbus, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Columbus, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials